VALUE-Dx is proud to present a workshop at the Virtual ISPOR Europe 2020 conference entitled ‘Assessing the Value of Point-of-Care Diagnostics: Economic Analyses and Appraisals’. The Professional Society for Health Economics and Outcomes Research (ISPOR) virtual conference is taking place 16-19 November with a theme ‘Improving Health: Establishing Incentives and Sharing Value’. The conference will question the fundamental conventions around value, risk, rewards, and the role of public and private sectors.
About the workshop
Purpose
Diagnostic testing is an essential part of modern medicine, but only recently, due to the COVID-19 outbreak, did it gain substantial attention among the general public. VALUE-Dx is an IMI-funded consortium with the objective to assess and demonstrate the value of diagnostic-driven treatment of community-acquired acute respiratory tract infections (CA-ARTI) for both individual patients and public health. Within this consortium, academic, private and (inter)governmental institutions collaborate in many scientific fields: ranging from microbiology and economics to sociology and data science.
Inappropriate prescribing of antibiotics can lead to greater antimicrobial resistance of infectious pathogens. More rapid and accurate diagnoses can reduce inappropriate prescribing and thereby combat antimicrobial resistance. The workshop will focus on the current state of economic models and the appraisal of point-of-care (POC) diagnostics, as well as provide practical guidance for modellers, in vitro diagnostic companies, and appraisal agencies to value diagnostic innovations.
Description
The workshop will cover the full process of assessing a new POC diagnostic:
- The appraisal of POC diagnostic tests, reflecting on what NICE have learned about the challenges of assessing the value of POC testing in the UK setting.
- The specific elements to consider when conceptualizing a health-economic model for POC diagnostics of infectious disease, based on a review of the literature;
- An example of a health-economic model to value POC diagnostics for CA-ARTI, which explains how the considerations of B were used to develop a flexible, individual-based model applicable to several European countries;
- The assessment of broader public health and economic benefits with respect to antimicrobial resistance over the medium- to long-term using advanced modelling techniques. During the workshop, the audience will be asked questions using live polling, which will also be used to inform ongoing research of the VALUE-Dx project.
Discussion Leaders
- Colm Leonard, MD, National Institute for Health and Care Excellence, Manchester, UK
- Paula Rojas, MA, Dept of Economics, University of La Rioja, Logroño, Spain
- Simon Van der Pol, PharmD, Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
- Isabelle Feldhaus, MSPH, PhD, The Organisation for Economic Co-operation and Development (OECD), Paris, France
